ID: | F02 | |
---|---|---|
Name: | Amiloride | |
Description: | ||
Labels: | ||
CAS: | 2609-46-3 | |
InChi Code: | InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15) |
Class_pH3: Class of membrane permeability at pH 3 i
Value | Source or prediction |
---|---|
L |
M1: Model at pH 3 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M7: Model at pH 3 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH5: Class of membrane permeability at pH 5 i
Value | Source or prediction |
---|---|
L |
M2: Model at pH 5 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M8: Model at pH 5 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH7.4: Class of membrane permeability at pH 7.4 i
Value | Source or prediction |
---|---|
L |
M3: Model at pH 7.4 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M9: Model at pH 7.4 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH9: Class of membrane permeability at pH 9 i
Value | Source or prediction |
---|---|
L |
M4: Model at pH 9 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M10: Model at pH 9 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_highest: Class of highest membrane permeability for pH range 3 to 9 i
Value | Source or prediction |
---|---|
L |
M5: Model for highest membrane permeability with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M11: Model for highest membrane permeability with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_logPo: Class of intrinsic membrane permeability i
Value | Source or prediction |
---|---|
L |
M6: Model for intrinsic membrane permeability (logPo) with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M12: Model for intrinsic membrane permeability (logPo) with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_FDA: BCS permeability class for FDA reference drugs i
Value | Source or prediction |
---|---|
L |
experimental value |
L |
Fig5_1: Decision tree based on models with hydrophobicity descriptors (FDA reference drugs for BCS permeability class) |
L |
Fig5_2: Decision tree based on the models with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Link | Resource description |
---|---|
DTXCID7023853 | US EPA CompTox Dashboard |